Biotech news
Biotech
A Roche subsidiary will be unable to block Amgen from producing the cancer drug Mvasi (bevacizumab), the Court of Appeals for the Federal Circuit has ruled. 7 July 2020
Biotech
The EPO’s May 2020 decision in G3/19, on the patentability of certain plants, was among the most controversial in the office’s history. Anna Gregson of Mathys & Squire explores the implications. 2 July 2020
Biotech
Yesterday’s UK Supreme Court decision in Kymab v Regeneron is expected to have profound implications for innovative life sciences companies, according to lawyers. 25 June 2020
Biotech
The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice. 24 June 2020
Asia-Pacific
Swiss healthcare company Roche has partnered with Chinese biotech Innovent Biologics to develop cell therapies and bispecific antibodies. 15 June 2020
Biotech
For a start-up looking to build a patent portfolio, where should you start—‘home-grown’ patents, or licensing others’ IP? 11 June 2020
Americas
Protein engineering company Codexis has accused competitor Codex DNA of trademark infringement through the use of a “virtually identical” mark. 27 May 2020
Americas
Canada’s Department of Agriculture and Agri-Food has accused a Washington-based nursery, a fruit seller, and a fruit grower of infringing a plant patent covering the Staccato type of cherry tree. 20 May 2020
Pharma
Sanofi is facing criticism after CEO Paul Hudson said the US was likely to have priority access on any COVID-19 vaccine produced by the French pharmaceutical company. 15 May 2020
Pharma
IP firm HGF has appointed two patent attorneys to partner, increasing the partner group to 63 partners. 11 May 2020